Clover Health CLOV 深 沪
等待开盘 07-03 09:30:00 美东时间
5.26
-0.130
-2.41%
华盛通- 最 高5.51
- 今 开5.40
- 成交量 578.54万股
- 最 低 5.20
- 昨 收 5.39
- 总市值 27.70亿
- 52周最高 5.59
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.58
- 委 比 38.55%
- 总股本 5.27亿
- 历史最高 28.85
- 量 比 0.69
- 振 幅 5.75%
- 历史最低 0.606
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多知名迷因股盘前交易上涨 诺基亚涨2.7% Clover Health涨1.5% CuriosityStream涨1.1%
知名“网红概念股”盘前交易走高，其中诺基亚涨2.7%，Clover Health上涨1.5%，CuriosityStream上涨1.1%。 译文内容由第三方软件...
06-30 17:20
Clover Health’s CMS Star Rating Upgrades Boost 2027 Outlook
Clover Health Investments ( ($CLOV) ) has provided an announcement. On June 9, ...
06-19 05:06
Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Vistra Corp. (NYSE:VST), adding it “went too high. It's come back down. I'm going to bless it.” On the earnings front, the company, on May 7, posted GAAP first-quarter net income of $1.029 million, while ongoing operations Adjusted...
06-18 20:23
Clover Health Restructures Leadership After Home-Care CEO Exit
Clover Health Investments ( ($CLOV) ) has provided an announcement. On June 15,...
06-17 04:42
美股大行评级 | 甲骨文绩后分歧大！5家上调，2家下调；Navan、Hinge Health、凯西通用获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从6美元升至10美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14美元升至14.5美元
06-12 11:32
美股夜盘 | Navan涨19.26%，Clover Health涨10.84%
Navan涨19.26%；Clover Health涨10.84%；Uranium Energy涨6.90%
06-11 15:01
期权扫描 | 一Put单狂飙50倍！超微电脑暴跌28%引爆多空大决战；狂赌年底AI持续！资金押注微软再涨46%
一Put单狂飙50倍！超微电脑暴跌28%引爆多空大决战；狂赌年底AI持续！资金押注微软再涨46%；看涨期权占比超80%，Robinhood成交活跃>>
06-11 13:44
Clover Health gets Medicare Star Rating upgrade
Clover Health (CLOV) added more than 10% in the premarket on Wednesday after the health insurer announced that the Centers for Medicare & Medicaid Services (CMS) has upgraded its Medicare Star Ratings...
06-10 21:05
Clover Health Announces That Its 2026 Star Rating Has Been Recalculated At 4.5 Following U.S. Court's Summary Judgement
On June 9, 2026, CMS informed Clover that, consistent with the Court's order, it has recalculated Clover's 2026 Star Rating as 4.5 Stars, and has instructed Clover to submit alternate bids at 4.5 Stars. The 4.5 Star Rating applies to Contract H5141, Clover's PPO plan, which covers over 97% of Clover...
06-10 20:40
